Biotech

Latest Articles

Cassava pays for $40M over presumably deceptive Alzheimer's improve

.Cassava Sciences has accepted to pay for $40 thousand to solve an inspection right into cases it cr...

Merck bags possibilities on Evaxion's AI-designed vaccine candidates

.Merck &amp Co. has grabbed choices on 2 Evaxion Biotech vaccine prospects, paying for $3.2 thousand...

Enanta's RSV antiviral crushes viral tons in problem study

.Enanta Pharmaceuticals has actually connected its own breathing syncytial infection (RSV) antiviral...

Biogen cans SAGE-324 cooperation after crucial shake fail

.Biogen has administered the final rites to its cooperation with Sage Therapies on SAGE-324, breakin...

AbbVie Parkinson's medicine from $8.7 B Cerevel buyout scores

.On the very same day that some Parkinson's illness drugs are actually being actually disputed, AbbV...

Arch closes $3B-plus fund to promote biopharma startups

.On the heels of a $3 billion fund coming from Bain Funding Lifestyle Sciences, Arch Project Allies ...

Orion to make use of Aitia's 'electronic twins' to locate brand new cancer drugs

.Finnish biotech Orion has actually snooped prospective in Aitia's "electronic twin" technician to d...

Windtree's shock med rears high blood pressure in most recent stage 2 gain

.While Windtree Therapeutics has actually struggled to develop the economic origins needed to make i...

2 cancer biotechs combine, developing global footprint

.OncoC4 is actually taking AcroImmune-- and its internal clinical production capabilities-- under it...

Amgen records 1st period 3 gain for $400M dermatitis medication

.Amgen has actually discussed (PDF) the 1st phase 3 data on its $400 million eczema medication, link...

Biogen, UCB file period 3 lupus gain after stopping working earlier test

.Biogen and also UCB's depend developing right into phase 3 astride a broken study wants to have pai...

Aptadir hopes brand-new RNA inhibitors may reverse challenging cancers cells

.Italian biotech Aptadir Therapies has actually launched with the promise that its pipeline of precl...

Wave surfs DMD results to regulatory authorities' doors, sending out stockpile

.Wave Lifestyle Sciences has actually satisfied its objective in a Duchenne muscular dystrophy (DMD)...

Sanofi tweezes brand new CSO from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is going back to the pharma crease, using up the...

Achilles trickles tissue treatment program, bandages for discharges after overlooking 'commercial feasibility' targets

.Achilles Rehabs has destroyed its own strategy. The English biotech is quiting working on its own c...

Aligos proclaims phase 2 MASH gain, lowering liver fat approximately 46%

.Aligos Therapeutics is declaring a midstage win in metabolic-dysfunction connected steatohepatitis ...

Basilea credit ratings $268M BARDA backing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's job creating brand-new antifungals has acquired a substantial improvement c...

Capricor sells Europe civil rights to late-stage DMD treatment for $35M

.Having currently scooped up the U.S. civil liberties to Capricor Therapies' late-stage Duchenne mus...

FDA scraps adcomm for Applied's rare disease medication

.After pushing back the selection date for Applied Therapeutics' metabolic condition medicine govore...

Novo inks $600M NanoVation bargain to study genetic drugs ex-liver

.Novo Nordisk is continuing its press into genetic medicines, accepting compensate NanoVation Rehabs...